To include your compound in the COVID-19 Resource Center, submit it here.

Motif delays NDA for iclaprim in ABSSSIs

Motif Bio plc (LSE:MTFB; NASDAQ:MTFB) said it will delay submitting

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE